AIDS-related vasculopathy: Evidence for oxidative and inflammatory pathways in murine and human AIDS

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Baliga, Meshma S ^a   Chaves, Alysia A ^a   Jing, Liang ^a   Ayers, Leona W ^b   Bauer, John A ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c Division of Cardiovascular Medicine   (United States)

Author keywords

Endothelial function; Inflammation; Oxidants

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NITRATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; AORTA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDANTS; OXIDATIVE STRESS; SPECIFIC PATHOGEN-FREE ORGANISMS; VASCULITIS; VASOCONSTRICTION;

EID: 25444479069     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00304.2005     Document Type: Article

References (52)

1. Ambrose JA, Gould RB, Kurian DC, DeVoe MC, Pearlstein NB, Coppola JT, and Siegal FP. Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection. Am J Cardiol 92: 301-303, 2003.
2. Anonymous. Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance-United States, 1994-2000. MMWR Morb Mortal Wkly Rep 51: 595-598, 2002.
3. Anonymous. New AIDS cases, deaths hold steady: CDC report. Clin Infect Dis 33: i, 2001.
4. Antinori A, Giancola ML, Alba L, Soldani F, and Grisetti S. Cardiomyopathy and encephalopathy in AIDS. Ann NY Acad Sci 946: 121-129, 2001.
5. Appay V and Rowland-Jones SL. Premature ageing of the immune system: the cause of AIDS? Trends Immunol 23: 580-585, 2002.
6. Baliga RS, Liu C, Hoyt DG, Chaves AA, and Bauer JA. Vascular endothelial toxicity induced by HIV protease inhibitor: evidence of oxidant-related dysfunction and apoptosis. Cardiovasc Toxicol 4: 199-206, 2004.
7. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844, 1996.
8. Bonnet D, Aggoun Y, Szezepanski I, Bellal N, and Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 18: 1037-1041, 2004.
9. Bussolino F, Mitola S, Serini G, Barillari G, and Ensoli B. Interactions between endothelial cells and HIV-1. Int J Biochem Cell Biol 33: 371-390, 2001.
10. Chaves AA, Mihm MJ, Schanbacher BL, Basuray A, Lin C, Ayers LW, and Bauer JA. Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues. Cardiovasc Res 60: 108-118, 2003.
11. Chi D, Henry J, Kelley J, Thorpe R, Smith JK, and Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium 7: 223-242, 2000.
12. Chironi G, Escaut L, Gariepy J, Cogny A, Teicher E, Monsuez JJ, Levenson J, Simon A, and Vittecoq D. Carotid intima-media thickness in heavily pretreated HIV-infected patients. J Acquir Immune Defic Syndr 32: 490-493, 2003.
13. Constans J, Seigneur M, Blann AD, Renard M, Resplandy F, Amiral J, Guerin V, Boisseau MR, and Conri C. Effect of the antioxidants selenium and β-carotene on HIV-related endothelium dysfunction. Thromb Haemost 80: 1015-1017, 1998.
14. D'Amati G, di Gioia CR, and Gallo P. Pathological findings of HIV-associated cardiovascular disease. Ann NY Acad Sci 946: 23-45, 2001.
15. Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave JP, Riesen W, Nicod P, Darioli R, Telenti A, and Mooser V. Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy. AIDS 15: 329-334, 2001.
16. Escaut L, Monsuez JJ, Chironi G, Merad M, Teicher E, Smadja D, Simon A, and Vittecoq D. Coronary artery disease in HIV-infected patients. Intensive Care Med 29: 969-973, 2003.
17. Furchgott RF and Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
18. 2+ channel activity in angiotensin-hypertension. Hypertension 41: 1124-1130, 2003.
19. Govers R and Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280: F193-F206, 2001.
20. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, and Waters DD. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 109: 316-319, 2004.
21. Iida R, Yamada K, Mamiya T, Saito IC, Seishima M, and Nabeshima T. Characterization of learning and memory deficits in C57BL/6 mice infected with LP-BM5, a murine model of AIDS. J Neuroimmunol 95: 65-72, 1999.
22. Ippolito G, Galati V, Serraino D, and Girardi E. The changing picture of the HIV/AIDS epidemic. Ann NY Acad Sci 946: 1-12, 2001.
23. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 356: 1-11, 1998.
24. Kanmogne GD, Grammas P, and Kennedy RC. Analysis of human endothelial cells and cortical neurons for susceptibility to HIV-1 infection and co-receptor expression. J Neurovirol 6: 519-528, 2000.
25. Kawashima S. The two faces of endothelial nitric oxide synthase in the pathophysiology of atherosclerosis. Endothelium 11: 99-107, 2004.
26. Labarrere CA and Zaloga GP. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117: 499-507, 2004.
27. Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, and Gastaut JA. Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 5: 127-131, 1992.
28. Lewis W. Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV. J Mol Cell Cardiol 32: 2115-2129, 2000.
29. Liang B, Wang JY, and Watson RR. Murine AIDS, a key to understanding retrovirus-induced immunodeficiency. Viral Immunol 9: 225-239, 1996.
30. Luscher TF and Barton M. Biology of the endothelium. Clin Cardiol 20: II-3-II-10, 1997.
31. Maggi P, Serio G, Epifani G, Florentine G, Saracino A, Fico C, Perilli F, Lillo A, Ferraro S, Gargiulo M, Chirianni A, Angarano G, Regina G, and Pastore G. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS 14: F123-F128, 2000.
32. Mercie P, Thiebaut R, Lavignolle V, Pellegrin JL, Yvorra-Vives MC, Morlat P, Ragnaud JM, Dupon M, Malvy D, Bellet H, Lawson-Ayayi S, Roudaut R, and Dabis F. Evaluation of cardiovascular risk factors in HIV-1-infected patients using carotid intima-media thickness measurement. Ann Med 34: 55-63, 2002.
33. Mihm MJ, Coyle CM, Jing L, and Bauer JA. Vascular peroxynitrite formation during organic nitrate tolerance. J Pharmacol Exp Ther 291: 194-198, 1999.
34. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, and Bauer JA. Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res 49: 798-807, 2001.
35. Mihm MJ, Jing L, and Bauer JA. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J Cardiovasc Pharmacol 36: 182-187, 2000.
36. Morse HC III, Chattopadhyay SK, Makino M, Fredrickson TN, Hugin AW, and Hartley JW. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6: 607-621, 1992.
37. Palella FJ Jr, Delaney ICM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, and Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860, 1998.
38. Paoletti R, Gotto AM Jr, and Hajjar DP. Inflammation in atherosclerosis and implications for therapy. Circulation 109: III20-III26, 2004.
39. Ross R. The pathogenesis of atherosclerosis. Mech Ageing Dev 9: 435-440, 1979.
40. Shannon RP. SIV cardiomyopathy in non-human primates. Trends Cardiovasc Med 11: 242-246, 2001.
41. Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64: 749-774, 2002.
42. Stein JII, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, and Sosman JM. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation 104: 257-262, 2001.
43. Terada LS, Gu Y, and Flores SC. AIDS vasculopathy. Am J Med Sci 320: 379-387, 2000.
44. Turko IV and Murad F. Protein nitration in cardiovascular diseases. Pharmacol Rev 54; 619-634, 2002.
45. Watson RR. LP-BM5, a murine model of acquired immunodeficiency syndrome: role of cocaine, morphine, alcohol and carotenoids in nutritional immunomodulation. J Nutr 122: 744-748, 1992.
46. Watson RR. Murine models for acquired immune deficiency syndrome. Life Sci 44: iii-xv, 1989.
47. Watson RR. A murine retrovirus model for studies of the role of cofactors and ethanol in AIDS development. MDA Res Monogr 96: 166-180, 1990.
48. Wattanapitayakul SK and Bauer JA. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol Ther 89: 187-206, 2001.
49. Wattanapitayakul SK, Weinstein DM, Holycross BJ, and Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 14: 271-278, 2000.
50. Weinstein DM, Mihm MJ, and Bauer JA. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 294: 396-401, 2000.
51. Zhang J, Du Ester EJ, and Watson RR. Side-stream cigarette smoke accentuates immunomodulation during murine AIDS. Int Immunopharmacol 2: 759-766, 2002.
52. Zietz C, Hotz B, Sturzl M, Rauch E, Penning R, and Lohrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am J Pathol 149: 1887-1898, 1996.